▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁always 6.859375
▁accompanied 4.84375
▁by 0.09686279296875
▁negative 5.1328125
▁emot 0.89794921875
ional 1.779296875
▁experiences 3.1875
▁and 2.34375
▁blocks 11.8359375
▁a 4.0390625
▁person 0.71630859375
’ 0.62109375
s 0.0005564689636230469
▁ability 0.75927734375
▁to 0.01343536376953125
▁receive 7.4765625
▁joy 2.98046875
▁and 1.4140625
▁satisfaction 4.1953125
▁from 1.07421875
▁life 0.51708984375
. 0.1646728515625
▁Chron 2.470703125
ic 0.001880645751953125
▁pain 0.0706787109375
▁is 1.27734375
▁still 8.6796875
▁considered 2.796875
▁to 1.8017578125
▁be 0.0308837890625
▁an 2.51953125
▁extreme 6.86328125
▁issue 5.546875
▁among 4.1796875
▁at 9.609375
▁least 0.1832275390625
▁ 0.33642578125
8 3.267578125
% 2.287109375
▁of 0.08209228515625
▁the 0.418701171875
▁residents 7.6796875
▁of 0.3779296875
▁progress 11.59375
ive 0.044952392578125
▁countries 0.51416015625
. 0.6494140625
▁The 2.34765625
▁introduction 7.6015625
▁of 0.04193115234375
▁the 2.216796875
▁study 7.03125
▁describes 6.2890625
▁the 0.486083984375
▁apparent 10.21875
▁link 4.28125
▁between 0.11407470703125
▁pain 2.34765625
▁and 0.1695556640625
▁dem 8.765625
oral 1.4833984375
ization 0.11822509765625
. 1.1298828125
▁The 1.361328125
▁research 2.72265625
▁investig 5.37109375
ates 0.3955078125
▁the 0.416748046875
▁development 6.15625
▁of 0.158203125
▁de 3.607421875
pression 0.404052734375
▁and 1.298828125
▁anx 1.8779296875
iety 0.00091552734375
▁among 1.78125
▁patients 1.494140625
▁receiving 5.57421875
▁ph 6.125
arma 3.017578125
ce 0.01108551025390625
ut 0.0001081228256225586
ical 0.0052642822265625
▁op 4.62890625
io 0.12359619140625
ids 0.429443359375
▁and 2.4375
▁medical 4.31640625
▁mar 1.8125
iju 0.0012102127075195312
ana 5.316734313964844e-05
▁( 2.841796875
MM 1.1123046875
) 2.677734375
▁as 2.61328125
▁severe 10.1484375
▁pain 0.8505859375
kill 2.904296875
ers 0.0006780624389648438
. 0.2685546875
▁It 3.373046875
▁comp 5.0234375
ares 0.0088958740234375
▁the 0.60107421875
▁effic 4.55078125
acy 0.0020198822021484375
▁of 0.1553955078125
▁pres 6.03515625
cri 2.005859375
ptions 1.5732421875
▁and 2.158203125
▁exam 4.75
ines 0.0131072998046875
▁the 0.47216796875
▁possibility 3.927734375
▁of 0.1085205078125
▁post 7.984375
- 0.60400390625
tre 2.193359375
at 0.0016717910766601562
ment 0.004192352294921875
▁de 1.6064453125
pression 0.06427001953125
. 1.478515625
▁A 3.865234375
▁more 6.68359375
▁manage 8.4765625
able 0.0004715919494628906
▁and 2.44921875
▁sa 3.60546875
fer 0.00010514259338378906
▁alternative 2.119140625
▁might 6.046875
▁be 0.374755859375
▁medical 2.857421875
▁mar 0.2337646484375
iju 0.00067901611328125
ana 0.00012683868408203125
. 1.2041015625
▁They 7.23046875
▁manage 8.4609375
▁pain 2.009765625
▁successfully 5.68359375
, 1.8251953125
▁but 1.4453125
▁the 2.400390625
▁past 8.703125
▁few 2.833984375
▁dec 1.5830078125
ades 0.00021719932556152344
▁indicated 7.671875
▁the 2.26953125
▁growing 4.7734375
▁concern 2.99609375
▁regarding 2.576171875
▁op 3.64453125
iate 3.56640625
▁ab 1.6181640625
use 0.0128631591796875
▁in 3.677734375
▁forms 10.0859375
▁of 0.23681640625
▁over 3.740234375
d 0.1788330078125
ose 0.30859375
▁and 0.82666015625
▁add 0.8447265625
iction 0.0238189697265625
. 0.158203125
▁However 4.3671875
, 0.00685882568359375
▁the 1.7265625
▁legal 4.66015625
▁status 2.318359375
▁and 3.3515625
▁novel 9.484375
ty 1.474609375
▁of 0.1275634765625
▁this 4.53125
▁drug 2.267578125
▁do 5.0625
▁not 0.0255889892578125
▁allow 0.93017578125
▁finding 7.18359375
▁a 2.109375
▁large 3.34765625
▁number 0.7685546875
▁of 0.0033664703369140625
▁studies 1.36328125
▁on 1.4912109375
▁its 1.4501953125
▁effect 2.3515625
iveness 0.346923828125
. 0.82373046875
▁There 4.125
▁is 0.861328125
▁currently 5.015625
▁a 1.1240234375
▁severe 5.59375
▁lack 1.31640625
▁of 0.01274871826171875
▁information 2.18359375
▁about 1.3359375
▁the 0.79443359375
▁effects 2.927734375
▁of 0.12432861328125
▁op 3.755859375
i 1.7333984375
ates 0.00804901123046875
. 2.81640625
▁Part 7.1015625
icip 0.67431640625
ants 0.041290283203125
▁were 1.3486328125
▁rec 2.80859375
ru 0.0010881423950195312
ited 0.00013637542724609375
▁for 3.16796875
▁six 6.34765625
▁months 0.548828125
▁at 4.0546875
▁two 2.84375
▁major 4.35546875
▁pain 2.236328125
▁relief 4.9765625
▁cent 0.83935546875
ers 0.1253662109375
▁in 0.67822265625
▁Israel 3.912109375
. 0.421630859375
▁Specifically 8.5859375
, 0.04443359375
▁it 3.70703125
▁concerns 5.84375
▁the 1.7080078125
▁emot 7.09375
ional 0.0303955078125
▁condition 4.54296875
▁of 0.30517578125
▁patients 1.01953125
▁experien 5.71875
cing 3.2782554626464844e-05
▁chron 1.15234375
ic 0.00043654441833496094
▁pain 0.153076171875
. 1.1552734375
▁The 1.166015625
▁study 1.669921875
▁was 2.24609375
▁conducted 0.98974609375
▁in 1.2802734375
▁the 2.193359375
▁form 1.9150390625
▁of 0.002838134765625
▁collection 10.9140625
▁and 1.2060546875
▁analysis 0.560546875
▁of 0.0280303955078125
▁statistical 4.375
▁data 0.163818359375
. 0.84423828125
▁All 4.5859375
▁tools 7.59765625
▁in 5.25390625
▁the 0.4931640625
▁form 2.759765625
▁of 0.006031036376953125
▁question 0.625
na 0.00440216064453125
ires 0.00018775463104248047
▁and 1.5009765625
▁scales 2.296875
▁have 3.123046875
▁already 3.330078125
▁been 0.2431640625
▁used 2.291015625
▁and 2.02734375
▁proved 2.861328125
▁their 0.958984375
▁effic 3.517578125
acy 0.0027446746826171875
▁for 4.20703125
▁collect 4.3515625
ing 0.0025272369384765625
▁analyt 7.78515625
ical 0.038330078125
▁data 0.435546875
. 0.328369140625
▁The 1.0107421875
▁research 2.48046875
ers 1.9833984375
▁used 1.8857421875
▁The 7.1640625
▁De 2.708984375
pression 0.0297088623046875
▁Module 6.2578125
▁of 0.94140625
▁the 0.2060546875
▁Pat 4.04296875
ient 0.014434814453125
▁Health 0.07440185546875
▁Question 0.0288543701171875
naire 0.0205230712890625
▁and 3.015625
▁the 0.64404296875
▁General 1.7900390625
ized 0.87158203125
▁An 0.01300811767578125
x 0.00013566017150878906
iety 0.0003783702850341797
▁Dis 0.2103271484375
order 0.025604248046875
▁Sc 1.3173828125
ale 0.002300262451171875
▁to 1.56640625
▁interview 8.234375
▁participants 2.408203125
, 4.375
▁evaluate 4.88671875
▁their 0.76708984375
▁answers 4.22265625
, 0.492431640625
▁and 0.061279296875
▁conduct 4.78515625
▁the 2.25
▁study 2.37109375
. 0.1171875
▁This 4.03125
▁research 2.1953125
▁paper 4.6484375
▁a 2.716796875
ims 0.0012540817260742188
▁to 0.05889892578125
▁analyze 3.193359375
▁levels 9.2734375
▁of 0.03240966796875
▁de 0.5595703125
pression 0.032318115234375
▁and 0.1868896484375
▁anx 0.03875732421875
iety 0.00026869773864746094
▁among 0.94921875
▁people 2.90234375
▁receiving 2.28125
▁ther 6.56640625
apy 0.076904296875
▁by 4.9765625
▁comparing 6.453125
▁the 1.4296875
▁effects 2.423828125
▁of 0.0309295654296875
▁ph 2.703125
arma 0.044708251953125
ce 0.0017538070678710938
ut 1.811981201171875e-05
ical 0.002964019775390625
▁op 0.22265625
io 0.367431640625
ids 0.045318603515625
▁and 0.267578125
▁MM 0.9013671875
. 0.40673828125
▁Perhaps 9.4140625
▁some 5.80859375
▁patients 2.693359375
▁tend 6.765625
▁to 0.01122283935546875
▁ex 5.84765625
agger 0.049774169921875
ate 0.0029239654541015625
▁their 0.9599609375
▁de 3.404296875
press 1.5498046875
ive 0.0249481201171875
▁state 2.818359375
▁or 2.47265625
▁vice 6.07421875
▁vers 0.0084381103515625
a 0.0004436969757080078
, 1.025390625
▁de 5.96875
- 3.765625
emph 0.64111328125
as 0.004169464111328125
ize 0.052001953125
▁serious 6.55859375
▁difficulties 5.67578125
. 0.7294921875
▁To 4.25390625
▁specifically 10.3359375
▁evaluate 2.974609375
▁and 3.94921875
▁compare 1.3447265625
▁the 0.480224609375
▁prob 9.6796875
abilities 0.08673095703125
▁of 0.1348876953125
▁de 0.83447265625
pression 0.0953369140625
▁or 3.64453125
▁anx 0.1103515625
iety 0.0004589557647705078
▁among 1.69140625
▁the 2.220703125
▁diverse 9.8203125
▁groups 1.0654296875
, 0.9814453125
▁the 0.78125
▁study 2.091796875
▁used 1.8544921875
▁multiple 5.5078125
▁log 2.232421875
istic 0.03240966796875
▁regression 0.2354736328125
▁analysis 1.318359375
▁and 2.89453125
▁chose 8.1328125
▁medical 6.05859375
▁mar 0.10137939453125
iju 0.001071929931640625
ana 5.3763389587402344e-05
▁as 0.447998046875
▁the 1.0859375
▁control 2.740234375
▁group 0.497802734375
. 0.2269287109375
▁Because 6.82421875
▁the 1.80078125
▁survey 6.02734375
▁responses 6.71875
▁were 1.2802734375
▁thoroughly 8.671875
▁anonymous 3.2734375
, 0.2425537109375
▁the 0.9775390625
▁research 1.087890625
ers 0.2484130859375
▁were 1.8291015625
▁unable 1.58984375
▁to 0.001605987548828125
▁carefully 8.71875
▁analyze 2.80859375
▁each 2.822265625
▁patient 1.4111328125
’ 0.3134765625
s 0.0004723072052001953
▁reaction 5.05859375
▁and 2.04296875
▁compare 3.912109375
▁it 1.1962890625
▁to 0.353515625
▁the 0.86328125
▁actual 5.015625
▁states 8.25
▁of 0.3896484375
▁condition 8.0078125
. 0.499755859375
▁This 3.26953125
▁type 5.19921875
▁of 0.003284454345703125
▁study 1.5029296875
▁is 1.482421875
▁the 4.05859375
▁most 1.4140625
▁reve 7.53125
aling 0.000606536865234375
▁and 1.5322265625
▁inclus 7.375
ive 0.0010738372802734375
, 2.05078125
▁as 1.9296875
▁it 0.406005859375
▁contains 4.5
▁direct 6.67578125
▁responses 3.841796875
▁from 0.57763671875
▁a 3.12890625
▁large 0.90185546875
▁number 0.48291015625
▁of 0.00222015380859375
▁participants 1.4970703125
. 0.5615234375
▁However 2.736328125
, 0.001064300537109375
▁this 2.732421875
▁method 2.521484375
▁of 1.9541015625
▁research 1.8779296875
▁is 1.5703125
▁way 10.640625
▁more 1.5888671875
▁resource 6.265625
- 0.329345703125
int 0.9873046875
ensive 0.01256561279296875
▁and 0.837890625
▁energy 9.796875
- 0.08135986328125
consum 0.326171875
ing 0.0014238357543945312
. 0.91064453125
▁It 2.453125
▁helps 6.41015625
▁to 0.623046875
▁system 6.96484375
at 0.3759765625
ize 0.0018463134765625
▁and 1.3291015625
▁class 4.52734375
ify 0.0014247894287109375
▁distinct 8.1171875
▁kinds 6.40625
▁of 0.0218658447265625
▁information 2.93359375
▁for 4.4765625
▁subsequent 4.859375
▁un 8.5390625
comp 4.046875
licated 0.0219573974609375
▁services 11.75
. 0.64111328125
▁More 6.41796875
▁accurate 4.3046875
▁answers 4.16015625
▁could 3.947265625
▁be 0.51806640625
▁obtained 0.96142578125
▁by 1.3359375
▁professional 6.81640625
▁psych 1.64453125
olog 0.25830078125
ists 0.0005598068237304688
▁via 6.3203125
▁personal 2.8125
▁communication 3.67578125
▁and 2.19921875
▁behavior 6.37109375
al 0.208740234375
▁analysis 1.912109375
. 0.272216796875
▁Thus 4.65234375
, 0.012054443359375
▁research 4.24609375
ers 0.348876953125
▁can 2.302734375
▁compare 3.81640625
▁the 0.900390625
▁effects 3.01953125
▁of 0.10406494140625
▁medic 3.875
ations 0.75830078125
▁on 1.2646484375
▁patients 2.015625
▁of 4.06640625
▁diverse 3.904296875
▁age 2.091796875
▁groups 1.9326171875
, 0.83203125
▁background 4.0
s 0.1329345703125
, 0.0238494873046875
▁physical 5.3125
▁conditions 1.4609375
, 0.051361083984375
▁emot 5.6796875
ional 0.0242919921875
▁states 0.93310546875
, 0.0633544921875
▁and 0.400390625
▁so 2.767578125
▁on 0.26123046875
. 0.059844970703125
▁All 4.81640625
▁patients 3.537109375
▁experienced 4.68359375
▁chron 0.8408203125
ic 0.0002512931823730469
▁pain 0.1103515625
▁for 2.859375
▁at 0.7763671875
▁least 0.0020599365234375
▁ 1.70703125
3 1.5205078125
▁months 0.27490234375
. 1.2373046875
▁The 1.47265625
▁analysis 4.44921875
▁of 1.17578125
▁any 8.171875
▁human 7.1171875
▁reaction 3.46875
▁has 4.8125
▁a 1.7861328125
▁high 3.177734375
▁potential 3.130859375
▁of 1.919921875
▁subject 2.955078125
iveness 3.85546875
▁and 1.1923828125
▁bias 1.982421875
, 1.84765625
▁especially 2.501953125
▁regarding 3.744140625
▁people 4.94140625
▁in 3.458984375
▁severe 2.5625
▁pain 0.91357421875
▁and 2.54296875
▁un 5.60546875
stable 1.154296875
▁emot 0.69873046875
ional 0.053466796875
▁condition 2.529296875
. 0.044036865234375
▁Part 4.8828125
icip 0.1702880859375
ants 0.040283203125
▁were 1.220703125
▁rec 2.8046875
ru 0.0003597736358642578
ited 8.082389831542969e-05
▁for 1.310546875
▁six 0.21142578125
▁months 0.00347900390625
▁at 0.1611328125
▁two 0.04742431640625
▁major 0.053375244140625
▁pain 0.025787353515625
▁relief 0.031982421875
▁cent 0.0137939453125
ers 0.0009126663208007812
▁in 0.033203125
▁Israel 0.0106048583984375
. 0.130859375
▁The 1.5478515625
▁study 1.646484375
▁included 2.515625
▁ 0.498046875
8 3.08984375
9 2.505859375
0 3.052734375
▁participants 2.01953125
, 1.513671875
▁of 2.607421875
▁which 0.53076171875
▁ 0.109130859375
4 1.263671875
7 2.603515625
4 2.609375
▁( 2.822265625
5 0.09088134765625
9 5.02734375
%) 0.83203125
▁were 0.7119140625
▁treated 3.142578125
▁sole 6.28125
ly 0.0002474784851074219
▁with 0.1947021484375
▁op 1.2099609375
io 0.340576171875
ids 0.10986328125
, 0.55126953125
▁ 0.7177734375
3 1.23828125
2 2.244140625
9 2.474609375
▁( 0.051055908203125
4 2.49609375
1 1.1181640625
%) 0.060638427734375
▁were 1.3017578125
▁treated 0.34228515625
▁with 0.44287109375
▁MM 0.7138671875
, 0.397705078125
▁and 0.08984375
▁ 0.240966796875
7 2.095703125
7 2.3828125
▁( 0.10076904296875
8 2.087890625
. 0.87451171875
6 2.60546875
%) 0.069091796875
▁acquired 10.609375
▁both 0.59423828125
▁( 4.69140625
Fe 10.2421875
ing 1.345703125
old 0.314697265625
▁et 0.8984375
▁al 0.01959228515625
., 0.180419921875
▁ 0.0112457275390625
2 0.00870513916015625
0 0.00020503997802734375
1 0.39990234375
7 1.7734375
). 0.0350341796875
▁The 1.14453125
▁remaining 7.73828125
▁ten 6.83984375
▁participants 1.5283203125
▁who 4.7109375
▁did 2.208984375
▁not 0.00635528564453125
▁receive 2.326171875
▁ph 4.078125
arma 0.10638427734375
ce 0.0010347366333007812
ut 1.430511474609375e-06
ical 0.0020809173583984375
▁op 1.30078125
io 0.0533447265625
ids 0.0238189697265625
▁and 2.369140625
▁medical 1.65234375
▁mar 0.044403076171875
iju 0.0002956390380859375
ana 3.695487976074219e-05
▁were 0.53369140625
▁with 6.421875
dra 0.054107666015625
wn 2.4199485778808594e-05
▁from 0.275146484375
▁the 0.1702880859375
▁analysis 2.28515625
▁in 5.015625
▁the 1.3232421875
▁research 4.3203125
. 0.9521484375
▁It 3.48046875
▁evaluated 9.4140625
▁the 0.52392578125
▁inter 6.91015625
dep 3.126953125
end 0.00017654895782470703
ence 0.00472259521484375
▁of 0.5009765625
▁various 3.88671875
▁factors 0.86572265625
▁that 2.3125
▁affected 4.39453125
▁the 0.433349609375
▁physical 6.3046875
▁and 0.3310546875
▁emot 0.59765625
ional 8.428096771240234e-05
▁condition 1.41015625
▁of 0.1048583984375
▁patients 0.8447265625
▁experien 3.431640625
cing 1.1563301086425781e-05
▁chron 0.305419921875
ic 0.00018858909606933594
▁pain 0.01508331298828125
. 0.16455078125
▁The 1.099609375
▁study 1.6669921875
▁conducted 4.640625
▁a 1.4921875
▁correlation 5.4921875
▁type 9.4921875
▁of 0.220703125
▁research 0.82568359375
▁with 3.50390625
▁variable 8.4921875
▁measures 5.66796875
. 1.140625
▁The 1.2861328125
▁question 5.01953125
na 0.50244140625
ires 2.300739288330078e-05
▁used 2.396484375
▁different 6.34765625
▁variable 8.1015625
▁measures 0.87744140625
▁to 1.94921875
▁collect 2.279296875
▁information 2.046875
. 1.779296875
▁For 3.2109375
▁example 0.5439453125
, 0.004100799560546875
▁the 0.90869140625
▁survey 5.140625
▁showed 5.71875
▁that 1.0869140625
▁the 1.7255859375
▁ratio 6.59765625
▁of 0.10015869140625
▁female 3.55859375
▁patients 1.064453125
▁was 1.0068359375
▁remark 8.6796875
ably 0.00019168853759765625
▁higher 0.213623046875
▁in 3.052734375
▁the 0.578125
▁op 3.455078125
i 3.1328125
ates 0.0212860107421875
▁group 0.1878662109375
▁compared 2.580078125
▁to 0.05194091796875
▁the 0.484130859375
▁MM 0.2305908203125
▁group 0.2244873046875
. 0.385986328125
▁Therefore 4.56640625
, 0.00868988037109375
▁it 1.9404296875
▁is 1.1162109375
▁not 2.943359375
▁possible 1.716796875
▁to 0.0090179443359375
▁compreh 6.51171875
ens 0.159912109375
ively 0.0118255615234375
▁compare 1.82421875
▁patients 4.1015625
▁taking 5.26953125
▁medic 3.6953125
ations 0.56005859375
▁with 1.513671875
▁those 1.6318359375
▁who 0.89892578125
▁do 1.3515625
▁not 0.0034961700439453125
. 0.93505859375
▁In 3.353515625
▁turn 5.21875
, 0.0012464523315429688
▁people 5.171875
▁on 4.453125
▁op 1.5537109375
i 0.55078125
ates 0.0013322830200195312
▁were 1.6328125
▁more 1.3798828125
▁likely 0.28271484375
▁to 0.037445068359375
▁report 2.845703125
▁major 6.2109375
▁de 0.487060546875
press 0.6875
ive 0.0018463134765625
▁dis 0.904296875
orders 1.466796875
. 1.6220703125
▁The 1.677734375
▁third 7.51953125
▁measure 5.375
▁of 2.029296875
▁the 0.728515625
▁question 2.15234375
naire 0.1395263671875
▁was 1.5849609375
▁indicated 10.3828125
▁by 1.5380859375
▁information 7.87890625
▁on 1.8046875
▁any 5.74609375
▁twelve 14.015625
- 0.1871337890625
month 0.0948486328125
▁and 5.46484375
▁lifetime 1.224609375
▁drug 4.78515625
▁and 2.255859375
▁alco 0.1673583984375
hol 8.165836334228516e-05
▁consumption 5.5390625
. 0.44091796875
▁Pat 3.798828125
ients 0.025970458984375
▁were 2.82421875
▁also 2.271484375
▁asked 0.76953125
▁about 1.09765625
▁their 0.8935546875
▁medical 3.59375
▁history 0.49560546875
▁over 6.875
▁the 0.060150146484375
▁years 4.83984375
▁and 1.6962890625
▁the 1.7822265625
▁current 3.888671875
▁presence 4.359375
▁of 0.0701904296875
▁any 1.4033203125
▁severe 3.74609375
▁dise 2.22265625
ases 0.00012540817260742188
▁such 4.16796875
▁as 0.0011034011840820312
▁heart 2.712890625
▁failure 1.8720703125
, 0.447998046875
▁di 1.80859375
ab 0.0008225440979003906
etes 0.0029811859130859375
, 0.07080078125
▁ar 4.37109375
th 0.151123046875
rit 0.021697998046875
is 0.0037174224853515625
, 0.026214599609375
▁and 1.1552734375
▁so 0.70458984375
▁on 0.07098388671875
. 0.050262451171875
▁For 4.796875
▁example 1.2900390625
, 0.0010328292846679688
▁it 2.970703125
▁included 4.6171875
▁compreh 8.515625
ensive 0.038299560546875
▁so 6.71484375
cio 0.0008864402770996094
- 0.444091796875
dem 0.32470703125
ographic 0.057891845703125
▁data 1.01171875
: 4.72265625
▁gender 1.9296875
, 0.049407958984375
▁age 0.3115234375
, 0.045684814453125
▁country 4.55078125
, 2.6328125
▁type 4.65234375
▁of 0.058746337890625
▁residence 3.09375
▁( 2.228515625
urban 0.728515625
/ 1.57421875
r 0.159912109375
ural 0.0013208389282226562
), 0.1502685546875
▁years 5.77734375
▁of 0.1383056640625
▁education 0.5947265625
, 0.0987548828125
▁and 1.3251953125
▁employ 2.4609375
ment 0.0012998580932617188
▁status 0.65673828125
. 0.1875
▁The 1.287109375
▁pl 11.8046875
ur 1.0244140625
ality 0.00696563720703125
▁of 0.0816650390625
▁anx 8.078125
iety 0.014617919921875
▁contained 10.2421875
▁ 1.9150390625
4 1.9375
8 2.583984375
. 1.0068359375
4 2.271484375
% 0.2408447265625
▁among 2.451171875
▁OP 8.9375
▁patients 1.25
, 0.95751953125
▁ 1.177734375
2 2.134765625
1 2.72265625
. 0.09503173828125
5 2.125
% 0.02606201171875
▁among 0.34912109375
▁MM 0.1302490234375
▁patients 0.2069091796875
, 0.05364990234375
▁and 0.056427001953125
▁ 0.1131591796875
3 1.6103515625
8 2.65625
. 0.135498046875
7 2.244140625
% 0.021392822265625
▁among 0.18017578125
▁OP 2.958984375
MM 5.27734375
▁participants 4.18359375
. 0.30224609375
▁In 3.064453125
▁addition 1.9599609375
, 0.13134765625
▁the 1.08984375
▁record 10.125
▁included 3.037109375
▁a 2.71484375
▁pain 5.90625
▁measurement 4.921875
▁scale 0.96142578125
▁from 4.3828125
▁ 0.46435546875
0 0.360595703125
▁to 0.199951171875
▁ 0.00623321533203125
1 0.0804443359375
0 0.03399658203125
▁to 3.365234375
▁evaluate 1.5087890625
▁dis 6.09375
com 0.08685302734375
fort 0.0016965866088867188
▁feelings 8.046875
▁during 4.28515625
▁the 0.374267578125
▁last 1.2666015625
▁month 1.8984375
. 0.216796875
▁Among 5.17578125
▁all 2.427734375
▁participants 1.5654296875
▁in 3.587890625
▁the 0.2249755859375
▁study 0.63330078125
, 0.04949951171875
▁ 0.84814453125
4 1.9521484375
2 2.3203125
. 0.45947265625
2 2.205078125
% 0.047943115234375
▁suffered 3.400390625
▁from 0.06866455078125
▁de 2.44140625
pression 0.27587890625
, 0.92529296875
▁and 1.5947265625
▁ 0.19482421875
3 1.3828125
7 2.326171875
% 2.66796875
▁experienced 1.96875
▁excess 6.5625
ive 0.024078369140625
▁anx 0.21826171875
iety 0.0014944076538085938
. 0.322998046875
▁Pat 3.919921875
ients 0.0276336669921875
▁who 1.744140625
▁took 2.111328125
▁strong 9.21875
▁op 0.60986328125
i 0.82470703125
ates 0.0034027099609375
▁were 1.2724609375
▁t 9.984375
ended 1.09375
▁to 0.00611114501953125
▁place 9.6796875
▁their 1.9072265625
▁pain 1.0625
▁on 1.92578125
▁a 0.603515625
▁scale 1.68359375
▁of 0.396484375
▁ 0.1370849609375
9 2.76171875
▁to 2.09765625
▁ 0.01214599609375
1 0.004673004150390625
0 0.00588226318359375
▁( 2.73828125
Fe 1.2529296875
ing 0.0028820037841796875
old 0.0004265308380126953
▁et 0.02069091796875
▁al 0.001819610595703125
., 0.01153564453125
▁ 0.0015392303466796875
2 0.00018525123596191406
0 0.00016224384307861328
1 0.003204345703125
7 0.00801849365234375
). 0.009033203125
▁Pat 4.015625
ients 0.0235595703125
▁who 1.109375
▁took 1.287109375
▁only 5.0078125
▁MM 0.416748046875
▁or 3.083984375
▁mixed 4.09765625
▁medic 1.2001953125
ations 0.260009765625
▁course 13.6484375
▁had 2.21484375
▁a 1.1142578125
▁significantly 2.537109375
▁more 5.0078125
▁stable 3.146484375
▁emot 1.06640625
ional 0.0011005401611328125
▁state 0.56103515625
▁and 1.73828125
▁cop 7.23828125
ed 0.0853271484375
▁with 0.2269287109375
▁pain 0.74169921875
▁more 1.7294921875
▁manage 6.4765625
able 1.0654296875
. 0.348388671875
▁They 3.837890625
▁were 1.927734375
▁also 2.0859375
▁an 9.1953125
gu 7.0859375
ished 0.1650390625
▁em 7.32421875
otion 0.0036563873291015625
ally 0.0019063949584960938
▁and 1.568359375
▁react 7.6015625
ed 0.025146484375
▁rad 9.28125
ically 0.0006809234619140625
▁neg 5.81640625
atively 0.001522064208984375
▁to 0.22119140625
▁almost 6.52734375
▁all 1.2666015625
▁survey 3.990234375
▁questions 0.283447265625
. 0.290771484375
▁The 1.6650390625
▁pl 5.2265625
ur 0.006366729736328125
ality 0.00015044212341308594
▁of 0.025543212890625
▁de 2.494140625
press 2.052734375
ive 0.0255889892578125
▁dis 2.18359375
orders 0.1591796875
▁among 2.236328125
▁patients 1.1689453125
▁in 2.94921875
▁the 0.34912109375
▁op 1.134765625
i 0.486572265625
ates 0.0023860931396484375
, 8.3671875
▁medical 2.849609375
▁mar 0.0193634033203125
iju 0.0008001327514648438
ana 6.115436553955078e-05
, 0.1728515625
▁and 0.09375
▁mixed 0.90380859375
▁OP 6.64453125
MM 0.3095703125
▁groups 0.7705078125
▁number 8.421875
ed 0.01360321044921875
▁ 0.1287841796875
5 2.232421875
7 2.58203125
. 0.256591796875
1 2.19921875
%, 0.117431640625
▁ 0.004421234130859375
2 1.294921875
2 2.31640625
. 0.102294921875
3 2.2734375
%, 0.0498046875
▁and 0.0361328125
▁ 0.0018758773803710938
5 3.25390625
1 1.9033203125
. 0.1448974609375
4 2.189453125
%, 0.157470703125
▁respectively 0.017669677734375
. 0.1600341796875
▁It 3.021484375
▁can 3.671875
▁be 0.1287841796875
▁fairly 7.33203125
▁explained 4.1875
▁by 0.2076416015625
▁the 0.359619140625
▁weak 7.53125
▁focus 8.3046875
▁of 0.970703125
▁respond 7.15625
ents 0.05316162109375
▁who 2.75
▁have 4.35546875
▁overcome 7.52734375
▁severe 2.236328125
▁pain 0.8984375
▁sens 6.96484375
ations 0.1536865234375
▁and 1.287109375
▁de 4.5703125
press 1.212890625
ive 0.08282470703125
▁episodes 2.537109375
. 0.5341796875
▁One 5.84375
▁of 0.6357421875
▁the 0.0222015380859375
▁major 3.12890625
▁limitations 3.154296875
▁is 2.599609375
▁the 0.580078125
▁ins 4.80859375
u 0.080322265625
fficient 0.089111328125
ly 3.3125
▁high 3.068359375
▁response 2.712890625
▁rate 0.1025390625
, 2.0625
▁ 4.5078125
5 1.7724609375
7 2.474609375
% 2.052734375
▁instead 5.93359375
▁of 0.002559661865234375
▁ 0.59033203125
7 1.474609375
0 0.469482421875
% 1.5009765625
▁( 1.7001953125
Fe 0.472900390625
ing 0.0013866424560546875
old 0.0002868175506591797
▁et 0.00836181640625
▁al 0.0004363059997558594
., 0.005298614501953125
▁ 0.0011043548583984375
2 9.107589721679688e-05
0 5.3763389587402344e-05
1 0.0003101825714111328
7 0.00394439697265625
). 0.007366180419921875
▁It 2.529296875
▁is 1.20703125
▁not 2.716796875
▁clear 2.7578125
▁how 2.04296875
▁to 3.3046875
▁use 4.3671875
▁these 2.541015625
▁statistics 3.794921875
, 2.794921875
▁as 0.90673828125
▁they 1.95703125
▁still 5.5390625
▁may 4.984375
▁be 1.072265625
▁relevant 6.49609375
▁for 1.955078125
▁the 1.841796875
▁overall 4.75
▁analysis 2.677734375
. 0.84326171875
